|
|
adMare BioInnovations Appoints John DeLucchi, Martin LeBlanc, and Tim van Biesen to their Board of Directors
|
Vancouver, BC, October 9, 2023--adMare BioInnovations announced the appointment of John DeLucchi, President & CEO of Madison Venture Corporation, Martin LeBlanc, Co-Founder and Vice-Chairman of CellCarta Biosciences, and Tim van Biesen, head of the Global Healthcare & Life Sciences practice at Bain & Company, to its Board of Directors.
|
|
|
|
|
|
|
|
|
|
|
adMare BioInnovations Portfolio Company SoundBite Receives FDA 510(k) Clearance
|
Vancouver, BC, February 10, 2020--SoundBite Medical Solutions Inc.(SBMS), an adMare BioInnovations portfolio company, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SoundBiteâ„¢ Crossing System, a unique active wire technology for use in the treatment of peripheral chronic total occlusions (CTOs).
|
|
|
|
|
|